HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Farah Ballout Selected Research

Adenocarcinoma

4/2024Targeting SMAD3 Improves Response to Oxaliplatin in Esophageal Adenocarcinoma Models by Impeding DNA Repair.
12/2023Reflux conditions induce E-cadherin cleavage and EMT via APE1 redox function in oesophageal adenocarcinoma.
9/2023Differential Expression of NEK Kinase Family Members in Esophageal Adenocarcinoma and Barrett's Esophagus.
9/2022Targeting NRF2 Sensitizes Esophageal Adenocarcinoma Cells to Cisplatin through Induction of Ferroptosis and Apoptosis.
9/2022APE1 redox function is required for activation of Yes-associated protein 1 under reflux conditions in Barrett's-associated esophageal adenocarcinomas.
3/2022Unfolded Protein Response Is Activated by Aurora Kinase A in Esophageal Adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Farah Ballout Research Topics

Disease

13Neoplasms (Cancer)
04/2024 - 01/2018
6Adenocarcinoma
04/2024 - 03/2022
3Colorectal Neoplasms (Colorectal Cancer)
03/2022 - 01/2019
3Prostatic Neoplasms (Prostate Cancer)
08/2020 - 01/2018
2Gastroesophageal Reflux (GERD)
12/2023 - 09/2022
2Colonic Neoplasms (Colon Cancer)
09/2022 - 02/2019
2Glioblastoma (Glioblastoma Multiforme)
02/2021 - 02/2021
1Ataxia Telangiectasia (Louis Bar Syndrome)
04/2024
1Barrett Esophagus (Barrett's Esophagus)
09/2023
1Neuroblastoma
02/2021
1Inflammation (Inflammations)
01/2020
1Ichthyosis (Xeroderma)
10/2017
1Photophobia (Light Sensitivity)
10/2017
1Inborn Genetic Diseases (Disease, Hereditary)
10/2017

Drug/Important Bio-Agent (IBA)

4Proteins (Proteins, Gene)FDA Link
04/2024 - 08/2020
4thymoquinoneIBA
03/2022 - 01/2018
3Fluorouracil (Carac)FDA LinkGeneric
09/2022 - 01/2019
3tideglusibIBA
02/2021 - 02/2021
2Bile Acids and Salts (Bile Acids)IBA
12/2023 - 09/2022
1Oxaliplatin (Eloxatin)FDA LinkGeneric
04/2024
1Protein Phosphatase 2 (Protein Phosphatase 2A)IBA
04/2024
1Cadherins (E-Cadherin)IBA
12/2023
1NIMA-Related KinasesIBA
09/2023
1Cisplatin (Platino)FDA LinkGeneric
09/2022
1PlatinumIBA
09/2022
1brusatolIBA
09/2022
1Reactive Oxygen Species (Oxygen Radicals)IBA
09/2022
1Aurora Kinase AIBA
03/2022
1TunicamycinIBA
03/2022
1MLN 8237IBA
03/2022
1Radiation-Sensitizing AgentsIBA
03/2022
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
02/2021
1Glycogen Synthase Kinase 3IBA
02/2021
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
08/2020
1Interleukin-6 (Interleukin 6)IBA
01/2020
1Matrix Metalloproteinases (MMPs)IBA
01/2020
1p38 Mitogen-Activated Protein KinasesIBA
01/2020
1Heterocyclic Compounds (Compounds, Heterocyclic)IBA
02/2019
1Therapeutic UsesIBA
02/2019
1benzonitrileIBA
02/2019
1Transcription Factors (Transcription Factor)IBA
10/2017
1Transient Receptor Potential ChannelsIBA
10/2017
1Peptide Hydrolases (Proteases)FDA Link
10/2017

Therapy/Procedure

6Therapeutics
04/2024 - 01/2018
2Drug Therapy (Chemotherapy)
02/2021 - 02/2019
2Castration
01/2020 - 01/2018
1Radiotherapy
03/2022
1Intraperitoneal Injections
08/2020